Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 12, 2021

SELL
$80.49 - $108.67 $4,990 - $6,737
-62 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $5,326 - $6,251
62 New
62 $5,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pacific Financial Group Inc Portfolio

Follow Pacific Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Financial Group Inc with notifications on news.